Macy’s stock price target kept at $9 by UBS on market share concerns

UBS reiterated a Sell on Macy’s with a $9 price target implying ~49% downside from the current $17.83 share price (stock -18% YTD, +64% 1yr). Macy’s reported stronger-than-expected Q4 2025 results (adjusted EPS $1.67 vs $1.56 consensus; revenue $7.6B vs $7.46B) but gave initial FY2026 guidance below Street and UBS projects a -1% five-year EPS CAGR, citing market-share loss and margin pressures. Multiple sell-side firms trimmed price targets and consensus earnings estimates are drifting lower despite the earnings beat, leaving a mixed yet cautious outlook with downside risk to the stock.

Analysis

The market is pricing Macy’s as a structural mid‑market loser rather than a cyclical lurch; that view understates the asymmetric second‑order impacts of inventory and SKU rationalization. Accelerated promotions to defend share will force higher inventory turns but also systematically compress gross margins by a sustained few hundred basis points as markdown cadence increases and luxury/fragrance mix reverts toward value categories.

Store closures and accounting-driven EPS noise create headline risk that will compress short‑term consensus estimates, but they also change the cost structure in ways investors misprice: fewer stores reduce fixed overhead but raise last‑mile and DC per‑unit costs and concentrate sales risk into fewer geographies and digital channels. That concentration favors competitors with superior digital personalization and faster replenishment (off‑price and beauty specialists) while creating a temporary arbitrage for discount channels if Macy’s leans hard into liquidation.

Key catalysts and timelines: near term (days–weeks) — analyst revisions and guidance commentary will swing sentiment; medium term (3–12 months) — holiday sales cadence, inventory clean‑ups and any announced real‑estate monetizations will crystallize upside or downside; longer term (12–36 months) — whether Macy’s can structurally rebuild margins via assortment, private label, or property monetization. A reversal would require proven margin stabilization (200–300bps improvement YoY) driven by SKU productivity and/or a credible large‑scale real estate monetization plan that funds meaningful buybacks or debt paydown.

Key Decisions for Investors

• Short Macy’s (M) equity, horizon 6–12 months. Size as a modest tactical position (1–2% NAV) expecting 30–50% downside if promotional/margin erosion persists; pair with a 15% stop relative outperformance vs SPX to limit event‑risk from better‑than‑expected holiday prints.
• Pair trade: short M / long TJX (TJX) at a 1:0.6 notional ratio, horizon 3–9 months. Thesis: structural share flow to off‑price/discount channels while Macy’s absorbs markdown pressure; target a 20–30% relative outperformance with downside protection via the long leg liquidity.
• Buy a defined‑risk options hedge: M 9–12 month put spread ~20–30% OTM (buy lower strike, sell higher strike) sized to risk 0.5–1% NAV. This creates ~3x–5x asymmetric payoff if Macy’s re‑rates lower following guidance/earnings misses while capping premium spent.
• Event play: monitor Macy’s real estate announcements. If management launches a large sale‑leaseback/REIT carve‑out, pivot to long M (or long debt) for a 6–18 month recovery trade sized opportunistically; risk/reward flips if proceeds are used for buybacks or debt reduction versus merely plugging operating shortfalls.